NAMSW vs UTHR
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
NAMSW does not have a complete income-statement cache yet.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
NAMSW currently screens at market cap $0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the NAMSW and UTHR stock pages for the full models.
Not investment advice.